A DNA recombination-based approach to eliminate papillomavirus infection

Gene Therapy

Volumn 12, Issue 6, 2005, Pages 534-540

  Carson, A ^a   Wang, Z ^a   Xiao, X ^a   Khan, S A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical cancer; DNA recombination; Papillomaviruses

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ADENO ASSOCIATED VIRUS; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA RECOMBINATION; DRUG MECHANISM; GENE CASSETTE; GENE CONSTRUCT; GENE EXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSFECTION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NORTHERN BLOTTING; OPEN READING FRAME; PAPILLOMA VIRUS; POLYADENYLATION; PRIORITY JOURNAL; RNA ISOLATION; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE, TUMOR; DEPENDOVIRUS; DNA; FEMALE; GANCICLOVIR; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; PAPILLOMAVIRUS INFECTIONS; RECOMBINATION, GENETIC; THYMIDINE KINASE; UTERINE CERVICAL NEOPLASMS; VIRUS REPLICATION;

ADENO-ASSOCIATED VIRUS; HERPES; HUMAN HERPESVIRUS 1; PAPILLOMAVIRUS;

EID: 15944419143     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302447     Document Type: Article

References (24)

1. Dell G, Gaston K. Contributions in the domain of cancer research: review of human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci 2001; 58: 1923-1942.
2. Stubenrauch F, Laimins LA. Human papillomaviruses: active and latent phases. Cancer Biol 1999; 9: 379-386.
3. Frauke Fehrmann F, Laimonis LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003; 22: 5201-5207.
4. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-350.
5. Ayers D et al. Homologous recombination between autonomously replicating plasmids in mammalian cells. Genetics 1985; 111: 375-388.
6. Thyagarajan B, McCormick-Graham M, Romero DP, Campbell C. Characterization of homologous DNA recombination activity in normal and immortal mammalian cells. Nucleic Acids Res 1996; 24: 4084-4091.
7. Kitamura Y, Yoshikura H, Kobayashi I. Homologous recombination in a mammalian plasmid. Mol Gen Genet 1990; 222 185-191.
8. Salomon B et al. A truncated herpes simplex virus thymidine kinase phosphorylates thymidine and nucleoside analogs and does not cause sterility in transgenic mice. Mol Cell Biol 1995; 15 5322-5328.
9. Edwards-Gilbert G, Veraldi KL, Milcarek C. Alternative poly(A) site selection in complex transcription units: means to an end? Nucleic Acids Res 1997; 25: 2547-2561.
10. Batt DB, Luo Y, Carmichael GG. Polyadenylation and transcription termination in gene constructs containing multiple tandem polyadenylation signals. Nucleic Acids Res 1994; 22: 2811-2816.
11. Maxwell IH, Harrison GS, Wood WM, Maxwell F. A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription. Bio Techniques 1989; 7: 276-280.
12. Rubnitz J, Subramani S. The minimum amount of homology required for homologous recombination in mammalian cells. Mol Cell Biol 1984; 4: 2253-2258.
13. McBride AA, Howley PM. Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number. J Virol 1991; 65: 6528-6534.
14. Hansen J, Qing K, Srivastava A. Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts. J Virol 2001; 75 4080-4090.
15. Demone RM, Cole CN. Patterns of polyadenylation site selection in gene constructs containing multiple polyadenylation signals. Mol Cell Biol 1988; 8: 4829-4839.
16. Cooke C, Hans H, Alwine JC. Utilization of splicing elements and polyadenylation signal elements in the coupling of polyadenylation and last-intron removal. Mol Cell Biol 1999; 19: 4971-4979.
17. Kuo HC, Nasim FH, Grabowski PJ. Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. Science 1991; 251: 1045-1050.
18. Xiao X, Li J, Samulski RJ. Production of high-titer adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
19. Venturoli S et al. Detection of adeno-associated virus DNA in female genital samples by PCR-ELISA. J Med Virol 2001; 64 577.
20. Sethi N, Palefsky J. Treatment of human papillomavirus (HPV) type 16-infected cells using herpes simplex virus type I thymidine kinase-mediated gene therapy transcriptionally regulated by the HPV E2 protein. Hum Gene Ther 2003; 14: 45-57.
21. Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973-985.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989.
23. Mizuno M, Yoshida J, Colosi P, Kurtzman G. Adeno-associated virus vector containing the herpes simplex virus thymidine kinase gene causes complete regression of intracerebrally implanted human gliomas in mice, in conjunction with ganciclovir administration. Jpn J Cancer Res 1998; 89: 76-80.
24. Fukui T et al. Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector. Oral Oncol 2001; 37: 211-215.